Skip to content
★ Sign in to follow
EH

Eric Hedrick

Autre
EQRx, Inc.Pharmacyclics IncEpizyme, Inc.
Total declarations
15
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€514k

Latest filing published 21 Dec 2021 for EQRx, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

No signal scores available.

Eric Hedrick: trading record in brief

Filings by Eric Hedrick span 3 companies, the busiest being Epizyme, Inc., Pharmacyclics Inc and EQRx, Inc. We count 15 filings; the first trade dates from 29 April 2011 and the latest from 17 December 2021.

The open-market record consists of 6 sales worth €514k, with no purchase. Besides market trades, the filings include 1 share grant and 6 option exercises.

The newest entry dates from 21 December 2021: a share grant, in EQRx, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Eric Hedrick

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ◆
    Chief Physician ExecutiveExecutivesEQRx, Inc.
    0SEC
    627,000 sharesCommon StockSEC:0000899243-21-049128:0
  • ◇
    Chief Medical OfficerExecutivesEpizyme, Inc.
    4,380 USD0SEC
    2,000 shares@ US$2.19Common Stock, par value $0.0001 per shareSEC:0001209191-14-063898:0
  • ▼
    Chief Medical OfficerExecutivesEpizyme, Inc.
    46,760 USD0SEC
    2,000 shares@ US$23.38Common Stock, par value $0.0001 per shareSEC:0001209191-14-063898:1
  • ◇
    Chief Medical OfficerExecutivesEpizyme, Inc.
    4,380 USD0SEC
    2,000 shares@ US$2.19Common Stock, par value $0.0001 per shareSEC:0001209191-14-057964:0
  • ▼
    Chief Medical OfficerExecutivesEpizyme, Inc.
    57,340 USD0SEC
    2,000 shares@ US$28.67Common Stock, par value $0.0001 per shareSEC:0001209191-14-057964:1
  • ◇
    Chief Medical OfficerExecutivesEpizyme, Inc.
    4,380 USD0SEC
    2,000 shares@ US$2.19Common Stock, par value $0.0001 per shareSEC:0001209191-14-053496:0
  • ▼
    Chief Medical OfficerExecutivesEpizyme, Inc.
    77,200 USD0SEC
    2,000 shares@ US$38.60Common Stock, par value $0.0001 per shareSEC:0001209191-14-053496:1
  • ◇
    Chief Medical OfficerExecutivesEpizyme, Inc.
    4,380 USD0SEC
    2,000 shares@ US$2.19Common Stock, par value $0.0001 per shareSEC:0001209191-14-047938:0
  • ▼
    Chief Medical OfficerExecutivesEpizyme, Inc.
    62,700 USD0SEC
    2,000 shares@ US$31.35Common Stock, par value $0.0001 per shareSEC:0001209191-14-047938:1
  • ◇
    Chief Medical OfficerExecutivesEpizyme, Inc.
    4,380 USD0SEC
    2,000 shares@ US$2.19Common Stock, par value $0.0001 per shareSEC:0001209191-14-042428:0
  • ▼
    Chief Medical OfficerExecutivesEpizyme, Inc.
    52,840 USD0SEC
    2,000 shares@ US$26.42Common Stock, par value $0.0001 per shareSEC:0001209191-14-042428:1
  • ◇
    Chief Medical OfficerExecutivesEpizyme, Inc.
    29,565 USD0SEC
    13,500 shares@ US$2.19Common Stock, par value $0.0001 per shareSEC:0001209191-14-009945:0
  • ▼
    Chief Medical OfficerExecutivesEpizyme, Inc.
    394,875 USD0SEC
    13,500 shares@ US$29.25Common Stock, par value $0.0001 per shareSEC:0001209191-14-009945:1
  • ●
    Vice PresidentExecutivesPharmacyclics Inc
    6,851 USD0SEC
    1,338 shares@ US$5.12Common StockSEC:0001209191-11-053999:0
  • ●
    Vice PresidentExecutivesPharmacyclics Inc
    14,408 USD0SEC
    2,814 shares@ US$5.12Common StockSEC:0001209191-11-025886:0

15 of 15 declarations